May 13, 2020
Oncopeptides announces that two abstracts on multiple myeloma have been accepted by the 2020 ASCO Annual Meeting
Media
May 12, 2020
Spruce Biosciences Announces Launch of CAHstudy.com to Initiate Screening of Patients for CAH Clinical Program
May 11, 2020
Strongbridge Biopharma plc Announces Completion of Enrollment of Phase 3 LOGICS Study for RECORLEV® (levoketoconazole) for Endogenous Cushing’s Syndrome
May 11, 2020
Orexo acquires exclusive US rights to commercialize deprexis®, a world-leading digital therapy to help patients manage the symptoms of depression
May 08, 2020
BONESUPPORT HOLDING AB (PUBL) – Publishes Q1 2020 Interim report
May 07, 2020
Targovax ASA: First quarter 2020 results
May 06, 2020
Strongbridge Biopharma plc Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 06, 2020
Spruce Biosciences Strengthens Leadership Team with Appointments of Samir Gharib as CFO and Dasharatha Reddy as VP of Pharmaceutical Development and Manufacturing
May 06, 2020
Oncopeptides has completed a directed share issue raising approximately SEK 1,414 million (USD 144 M)
May 06, 2020
Targovax announces that abstract on interim phase I clinical data from the phase I/II peritoneal trial is accepted at ASCO
